Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 103.86M | 80.42M | 55.20M | 23.69M | 4.79M |
Gross Profit | 59.29M | 33.83M | 1.73M | 6.64M | 1.29M |
EBITDA | -36.64M | -95.62M | -68.94M | -1.93M | -25.90M |
Net Income | -54.02M | -106.25M | -42.98M | -23.98M | -27.82M |
Balance Sheet | |||||
Total Assets | 268.06M | 298.72M | 348.34M | 363.06M | 21.36M |
Cash, Cash Equivalents and Short-Term Investments | 51.94M | 118.82M | 229.78M | 307.49M | 4.70M |
Total Debt | 14.53M | 1.39M | 31.69M | 9.95M | 16.66M |
Total Liabilities | 150.41M | 152.40M | 121.13M | 72.23M | 106.04M |
Stockholders Equity | 117.65M | 146.32M | 227.21M | 290.84M | -84.69M |
Cash Flow | |||||
Free Cash Flow | -62.04M | -82.47M | -98.92M | -74.37M | -29.86M |
Operating Cash Flow | -30.85M | -9.80M | -74.73M | -69.28M | -23.25M |
Investing Cash Flow | -1.40M | -123.11M | -23.88M | -5.08M | -6.61M |
Financing Cash Flow | 1.81M | -29.66M | 20.51M | 377.83M | 17.23M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $1.33B | 31.45 | 24.98% | 1.34% | -3.81% | -11.48% | |
73 Outperform | $104.04M | 65.29 | -3.47% | ― | ― | ― | |
65 Neutral | $1.80B | ― | -6.45% | ― | -1.75% | 68.19% | |
64 Neutral | $10.95B | 16.37 | 8.81% | 1.96% | 2.68% | -15.33% | |
61 Neutral | $1.43B | ― | -71.94% | ― | 35.63% | -335.37% | |
54 Neutral | $7.66M | 2.86 | 47.90% | ― | 28.01% | ― | |
43 Neutral | $59.67M | ― | -236.56% | ― | -6.61% | 40.20% |
On August 13, 2025, Evolv Technologies announced that its Chief Innovation Officer, Michael Ellenbogen, will resign from his position effective September 5, 2025, due to new time commitments, although he will remain on the Board of Directors. The company reported strong financial results for the second quarter of 2025, with a 29% increase in revenue year-over-year, reaching $32.5 million. Despite a net loss of $40.5 million, Evolv achieved an adjusted EBITDA of $2.0 million, signaling improved operational efficiency. The company has raised its revenue growth outlook for 2025 to 27%-30%, reflecting confidence in its market positioning and future profitability.
On July 1, 2025, Evolv Technologies Holdings, Inc. filed a post-effective amendment with the Securities and Exchange Commission to update its existing shelf registration statement. This procedural move was necessary due to a recent restatement that rendered the previous registration on Form S-3 ineffective, prompting a change to Form S-1 without registering additional securities.
On June 20, 2025, Evolv Technologies Holdings, Inc. held its annual meeting of stockholders, where 72.41% of the company’s Class A common stock was represented. During the meeting, Kevin Charlton, John Kedzierski, Kimberly Sheehy, and Bilal Zuberi were elected as Class I directors, and the compensation of the company’s named executive officers was approved. Additionally, PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2025.